As the vaccine companies throughout the world are in a race to deliver the Covid-19 vaccine. All eyes are on India which manufactures 60% of the world’s vaccines. But among all other cities in India. It is Hyderabad city which can manufacture a third of the global vaccine.
Firstly, the World’s leading researcher in touch with Indian companies. More than 180 corona vaccine developments are underway worldwide. About 25 of these vaccines are in the final stages of testing. That means, their impact on human beings is being assessed. Indian companies supplying 60% vaccine related to various diseases. Certainly, Their techniques and machines are modern. Given this, researchers and institutions engaged in the development of the corona vaccine are in touch with Indian. Especially Ahmedabad and Pune companies for their commercial production.
Hyderabad and Pune companies are preparing for the production of the corona vaccine. Moreover, many countries have succeeded in manufacturing the vaccine, that its commercial production will be in India. For this, the companies of Hyderabad and Pune are also developing their technology and capacity as per the requirement. The last round of the vaccine of Sanofi is under trial expected to completed in the first half of the year 2021.
The commercial production of the Covid-19 vaccine expected to be in Shanta Biotechnics, Hyderabad. Sanofi acquired Shanta Biotechnics in the year 2009. Hyderabad’s E Ltd. has an agreement with Baylor College of Medicine in Texas. On other hand, Johnson & Johnson has agreed to vaccine production. India Immunological Limited can manufacture about two crore vaccines. And, already for vaccine manufacturing on an order basis. The company is also in talks for commercial production of Russian vaccine Sputnik-5. A company called Aravado Pharma also joined the manufacture of the Corona vaccine. It has agreed with an AMERICAN company. Also involved in research and claims to equipped with vaccine production capacity by March 2021.
It manufactures vaccines for diseases like polio, diphtheria, tetanus, BCG, hepatitis-B, etc. The company can produce 1.5 billion vaccines annually. It has an agreement with five companies in the world for the production of the corona vaccine. These include AstraZeneca and Novawax. The Serum Institute, along with these companies, has promised to make one billion doses and 50% in India.
